FENC Earnings & Financial Statements
Fennec Pharmaceuticals Inc.
$9.98
-$0.20(-1.96%)
40
Overall
40
Value
36
Tech
44
Quality
Market Cap
$356.56M
Volume
207.58K
52W Range
$5.65 - $13.25
Target Price
$17.67
FENC earnings and financial statements: Fennec Pharmaceuticals Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
FENC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $44.64M | $47.54M | $21.25M | $1.53M |
| Cost of revenue | $3.76M | $3.18M | $1.26M | $86.0K |
| Operating income | -$6.35M | $2.48M | -$13.06M | -$22.74M |
| EBITDA | -$7.55M | $4.32M | -$12.37M | -$22.59M |
| Net income | -$9.74M | -$272.0K | -$16.05M | -$23.71M |
| EPS (diluted) | $-0.34 | $-0.02 | $-0.60 | $-0.90 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $70.55M | $44.95M | $26.86M | $26.94M |
| Total liabilities | $35.08M | $50.82M | $39.06M | $29.51M |
| Shareholders’ equity | $35.47M | -$5.87M | -$11.62M | -$2.57M |
| Cash and equivalents | $36.79M | $26.63M | $13.27M | $23.77M |
| Long-term debt | - | $18.07M | $288.0K | $24.64M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$12.54M | $26.98M | -$17.14M | -$18.06M |
| Free cash flow | -$12.54M | - | -$17.14M | -$18.06M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FENC | $9.98 | -2.0% | 207.58K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fennec Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW